A20-mediated deubiquitination of ERα in the microenvironment of CD163+ macrophages sensitizes endometrial cancer cells to estrogen. (1st February 2019)
- Record Type:
- Journal Article
- Title:
- A20-mediated deubiquitination of ERα in the microenvironment of CD163+ macrophages sensitizes endometrial cancer cells to estrogen. (1st February 2019)
- Main Title:
- A20-mediated deubiquitination of ERα in the microenvironment of CD163+ macrophages sensitizes endometrial cancer cells to estrogen
- Authors:
- Lv, Qiaoying
Xie, Liying
Cheng, Yali
Shi, Yue
Shan, Weiwei
Ning, Chengcheng
Xie, Bingying
Yang, Bingyi
Luo, Xuezhen
He, Qizhi
Zhu, Qin
Zhang, Yingli
Zhang, Zhenbo
Wang, Chenji
Chen, Xiaojun
Xu, Congjian - Abstract:
- Abstract: Continuous estrogen signaling is thought to be the main mechanism causing endometrial cancer (EC). Studies have demonstrated that CD163 + macrophages could promote the development of estrogen-dependent EC, but the mechanisms involved remain unclear. We found that CD163 + macrophages were the dominant macrophages in atypical endometrial hyperplasia and cancer, and their infiltration was positively associated with ERα expression. CD163 + macrophages mainly increased ERα protein levels but with little upregulatory effect on ESR1 (ERα coding gene) transcripts. The ubiquitin-editing enzyme A20, screened from the endometrial microarray obtained from mice receiving a high-fat diet and sustained estrogen-intervened, was highly expressed in endometrial lesions rich with CD163 + macrophages, and positively correlated with ERα expression. Similarly, A20 and ERα were both upregulated by CD163 + macrophages via cytokines such as IL1α, IL17A and TNFα. Mechanistically, A20 overexpression in EC cells prolonged ERα protein half-life without affecting ESR1 transcripts. A20 increased functional ERα protein levels and enhanced estrogen-driven EC cell proliferation through preventing ERα protein degradation by its deubiquitinase activity. Our study revealed that A20-mediated deubiquitination of ERα might be an important mechanism by which CD163 + macrophages sensitize EC cells to estrogen. Highlights: CD163 + macrophages sensitize EC cells to estrogen by mainly upregulating ERαAbstract: Continuous estrogen signaling is thought to be the main mechanism causing endometrial cancer (EC). Studies have demonstrated that CD163 + macrophages could promote the development of estrogen-dependent EC, but the mechanisms involved remain unclear. We found that CD163 + macrophages were the dominant macrophages in atypical endometrial hyperplasia and cancer, and their infiltration was positively associated with ERα expression. CD163 + macrophages mainly increased ERα protein levels but with little upregulatory effect on ESR1 (ERα coding gene) transcripts. The ubiquitin-editing enzyme A20, screened from the endometrial microarray obtained from mice receiving a high-fat diet and sustained estrogen-intervened, was highly expressed in endometrial lesions rich with CD163 + macrophages, and positively correlated with ERα expression. Similarly, A20 and ERα were both upregulated by CD163 + macrophages via cytokines such as IL1α, IL17A and TNFα. Mechanistically, A20 overexpression in EC cells prolonged ERα protein half-life without affecting ESR1 transcripts. A20 increased functional ERα protein levels and enhanced estrogen-driven EC cell proliferation through preventing ERα protein degradation by its deubiquitinase activity. Our study revealed that A20-mediated deubiquitination of ERα might be an important mechanism by which CD163 + macrophages sensitize EC cells to estrogen. Highlights: CD163 + macrophages sensitize EC cells to estrogen by mainly upregulating ERα protein. A20 and ERα were highly expressed in endometrial lesions rich with CD163 + macrophages. CD163 + macrophages upregulated A20 and ERα via cytokines. A20 forms a complex with ERα protein in cell nuclei to stabilize ERα protein. A20 stabilizes ERα protein through deubiquitination of ERα protein. … (more)
- Is Part Of:
- Cancer letters. Volume 442(2019)
- Journal:
- Cancer letters
- Issue:
- Volume 442(2019)
- Issue Display:
- Volume 442, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 442
- Issue:
- 2019
- Issue Sort Value:
- 2019-0442-2019-0000
- Page Start:
- 137
- Page End:
- 147
- Publication Date:
- 2019-02-01
- Subjects:
- Endometrial cancer -- CD163+ macrophages -- ERα -- A20 -- Deubiquitination
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03043835/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.canlet.2018.10.019 ↗
- Languages:
- English
- ISSNs:
- 0304-3835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.485000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9292.xml